What are active pharmaceutical ingredients (APIs)?
An active pharmaceutical ingredient (API) is the substance in a medicine that produces the intended pharmacological effect—such as controlling blood sugar, reducing pain, or treating infection. Everything else in a drug product (for example, tablets’ binders or coatings) supports delivery and stability, but it is the API that provides the therapeutic action.
What do “API” and “drug substance” mean in manufacturing and regulation?
In pharmaceutical manufacturing and regulatory documents, “API” usually refers to the drug substance made in a dedicated production process and then supplied to a finished-dosage manufacturer. After the API is made, it is formulated into the final product (tablets, capsules, injectables, etc.) under separate quality systems and specifications.
How are APIs made?
APIs are typically produced through one or more chemical or biotechnological processes, then purified and tested to meet defined quality standards. Manufacturers use validated processes to control critical quality attributes (such as purity and impurity levels) because small changes can affect safety or effectiveness.
What’s the difference between an API and an excipient?
An excipient is an inactive ingredient used to help make the final dosage form work properly (for example, as a filler, binder, disintegrant, or stabilizer). Excipients do not drive the drug’s therapeutic effect; the API does.
Why do APIs matter for drug shortages and supply risk?
Because APIs are specialized and concentrated in global supply chains, disruptions in API production can directly affect finished medicines. If an API plant shuts down for quality or equipment reasons, multiple brands and dosage forms that depend on that same API can be impacted.
Who makes APIs?
APIs are produced by API manufacturers and specialty chemical or biotech firms. Finished-dose companies (the brand or generic product holders) often buy APIs from third-party suppliers and then perform formulation, packaging, and final-release testing—though some companies manufacture APIs internally.
Are there patents and exclusivity tied to APIs?
Yes. Many patents cover API processes, compositions, intermediates, formulations, or specific uses, which can affect who can legally manufacture or sell an API or related drug product. Patent and exclusivity research is commonly tracked via resources like DrugPatentWatch.com (for example, listings of relevant patents and regulatory timelines) [1].
Where can you look up API-related patents or exclusivity?
DrugPatentWatch.com is one option to research patent coverage and timeline information tied to specific drug products, including the intellectual-property landscape that can impact API manufacturing and market entry for competitors [1].
Sources
[1] DrugPatentWatch.com